{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:48:02Z","timestamp":1794008882714,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":114,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s13311-023-01359-3","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:19:19Z","timestamp":1679861959000},"page":"758-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Seizure Rescue Therapies: Comparing Approved and Commonly Used Benzodiazepine Formulations"],"prefix":"10.1016","volume":"20","author":[{"given":"Gregory L.","family":"Krauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Elizebath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naluca","family":"Mwendaweli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01359-3_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1755-5949.2010.00139.x","article-title":"Acute administration of benzodiazepines as part of treatment strategies for epilepsy","volume":"17","author":"Wolf","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1007\/s13311-023-01359-3_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpeds.2019.05.034","article-title":"Seizure rescue medication use among US pediatric epilepsy providers: a survey of the pediatric epilepsy research consortium","volume":"212","author":"Wallace","year":"2019","journal-title":"J Pediatr"},{"key":"10.1007\/s13311-023-01359-3_bib3","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/epi.17346","article-title":"Recognizing seizure clusters in the community: the path to uniformity and individualization in nomenclature and definition","volume":"63","author":"Haut","year":"2022","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01359-3_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2018.05.013","article-title":"Seizure cluster: definition, prevalence, consequences, and management","volume":"68","author":"Jafarpour","year":"2019","journal-title":"Seizure"},{"key":"10.1007\/s13311-023-01359-3_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yebeh.2018.09.035","article-title":"Prevalence and predictors of seizure clusters: a prospective observational study of adult patients with epilepsy","volume":"88","author":"Detyniecki","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01359-3_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/21556660.2021.1962671","volume":"10","author":"Mesraoua","year":"2021","journal-title":"Seizure clusters J Drug Assess"},{"key":"10.1007\/s13311-023-01359-3_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","article-title":"Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial","volume":"366","author":"McIntyre","year":"2005","journal-title":"The Lancet"},{"key":"10.1007\/s13311-023-01359-3_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1474-4422(05)70178-2","article-title":"Buccal midazolam as rescue therapy for acute seizures","volume":"4","author":"Scott","year":"2005","journal-title":"The Lancet Neurology"},{"key":"10.1007\/s13311-023-01359-3_bib9","unstructured":"Clonazepam orally disintegrating tablets product insert. Available at: https:\/\/www.parpharm.com\/pdfs\/catalog\/generic\/Clonazepam_ODT_PI_20220420.pdf. Accessed 10 Nov 2022."},{"key":"10.1007\/s13311-023-01359-3_bib10","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1177\/0883073810368312","article-title":"Dissolving oral clonazepam wafers in the acute treatment of prolonged seizures","volume":"25","author":"Troester","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-023-01359-3_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01359-3_bib12","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.90.15_supplement.P1.265","article-title":"Acute treatment of prolonged and repetitive seizures in adults using sublingual administration of lorazepam intensol 2 mg\/ml solution (P1.265)","volume":"90","author":"Kwok","year":"2018","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01359-3_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1528-1157.1965.tb03786.x","article-title":"Treatment of status epilepticus with diazepam (Valium)","volume":"6","author":"Gastaut","year":"1965","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01359-3_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0404.1967.tb02102.x","article-title":"Acute treatment of epileptic seizures with diazepamum (Valium)","volume":"43","author":"Henriksen","year":"1967","journal-title":"Acta Neurol Scand"},{"key":"10.1007\/s13311-023-01359-3_bib15","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199806253382602","article-title":"A comparison of rectal diazepam gel and placebo for acute repetitive seizures","volume":"338","author":"Dreifuss","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01359-3_bib16","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.51.5.1274","article-title":"Treating repetitive seizures with a rectal diazepam formulation: a randomized study. The North American Diastat Study Group","volume":"51","author":"Cereghino","year":"1998","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01359-3_bib17","unstructured":"Diastat (diazepam rectal gel) Product Insert. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020648s014lbl.pdf. Accessed 10 Nov 2022."},{"key":"10.1007\/s13311-023-01359-3_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1525-5050(02)00559-0","article-title":"Adult patient perceptions of emergency rectal medications for refractory seizures","volume":"3","author":"Tatum","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01359-3_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2021.108013","article-title":"Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: results from an exit survey of a phase 3, open-label, repeat-dose safety study","volume":"121","author":"Penovich","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01359-3_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.eplepsyres.2014.04.007","article-title":"Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults","volume":"108","author":"Henney","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-023-01359-3_bib21","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/epi.16506","article-title":"Pharmacokinetics and safety of VALTOCO (NRL-1; diazepam nasal spray) in patients with epilepsy during seizure (ictal\/peri-ictal) and nonseizure (interictal) conditions: a phase 1, open-label study","volume":"61","author":"Hogan","year":"2020","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01359-3_bib22","unstructured":"Center for Drug Evaluation and Research. Clinical pharmacology review of Valtoco. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2020\/211635Orig1s000ClinPharmR.pdf. Accessed 11 Nov 2022."},{"key":"10.1007\/s13311-023-01359-3_bib23","unstructured":"Center for Drug Evaluation and Research. Clinical review of Valtoco. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2020\/211635Orig1s000MedR.pdf. Accessed 11 Nov 2022."},{"key":"10.1007\/s13311-023-01359-3_bib24","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/epi.17041","article-title":"Final results from a phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy","volume":"62","author":"Wheless","year":"2021","journal-title":"Epilepsia"},{"issue":"4","key":"10.1007\/s13311-023-01359-3_bib25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/epi.17177","article-title":"Use of second doses of Valtoco\u00ae (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study","volume":"63","author":"Sperling","year":"2022","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01359-3_bib26","doi-asserted-by":"crossref","first-page":"107983","DOI":"10.1016\/j.yebeh.2021.107983","article-title":"Lack of observed tolerance to diazepam nasal spray (Valtoco\u00ae) after long-term rescue therapy in patients with epilepsy: interim results from a phase 3, open-label, repeat-dose safety study","volume":"120","author":"Cascino","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01359-3_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2022.04.011","article-title":"Safety of diazepam nasal spray in children and adolescents with epilepsy: results from a long-term phase 3 safety study","volume":"132","author":"Tarquinio","year":"2022","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1007\/s13311-023-01359-3_bib28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/epi.17459","article-title":"A randomized, open-label, two-treatment crossover study to evaluate the effect of food on the pharmacokinetics of diazepam nasal spray in healthy adults","volume":"64","author":"Rogawski","year":"2023","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01359-3_bib29","first-page":"63","article-title":"Intranasal diazepam (Valtoco) and midazolam (Nayzilam) for seizure clusters","volume":"62","year":"2020","journal-title":"Med Lett Drugs Ther"},{"key":"10.1007\/s13311-023-01359-3_bib30","series-title":"Diazepam Oral Solution [package insert]","year":"2012"},{"key":"10.1007\/s13311-023-01359-3_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.1998.00781.x","article-title":"Midazolam pharmacokinetics following intravenous and buccal administration","volume":"46","author":"Schwagmeier","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1007\/s13311-023-01359-3_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","article-title":"Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial","volume":"353","author":"Scott","year":"1999","journal-title":"Lancet"},{"key":"10.1007\/s13311-023-01359-3_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2005.09.006","article-title":"Intranasal midazolam vs rectal diazepam in acute childhood seizures","volume":"34","author":"Bhattacharyya","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1007\/s13311-023-01359-3_bib34","unstructured":"Midazolam Intramuscular Autoinjector Product Insert. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/216359s000lbl.pdf. Accessed 30 Jan 2023."},{"key":"10.1007\/s13311-023-01359-3_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2011.03235.x","volume":"52","author":"Silbergleit","year":"2011","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01359-3_bib36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1528-1167.2009.02333.x","article-title":"A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations","volume":"51","author":"De Haan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01359-3_bib37","unstructured":"Center for Drug Evaluation and Research. Clinical review of Nayzilam. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2020\/211635Orig1s000ClinPharmR.pdf. Accessed 11 Nov 2022."},{"key":"10.1007\/s13311-023-01359-3_bib38","unstructured":"Center for Drug Evaluation and Research. Clinical Pharmacology and Biopharmaceutics Review of Nayzilam. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/211321Orig1s000ClinPharmR.pdf. Accessed 11 Nov 2022."},{"key":"10.1007\/s13311-023-01359-3_bib39","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/epi.15159","article-title":"Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters\u2014a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Detyniecki","year":"2019","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01359-3_bib40","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/epi.16696","article-title":"Safety and tolerability associated with chronic intermittent use of diazepam buccal film in adult, adolescent, and pediatric patients with epilepsy","volume":"61","author":"Seinfeld","year":"2020","journal-title":"Auton Autacoid Pharmacol"},{"issue":"Pt B","key":"10.1007\/s13311-023-01359-3_bib41","doi-asserted-by":"crossref","first-page":"106537","DOI":"10.1016\/j.yebeh.2019.106537","article-title":"Diazepam buccal film for the treatment of acute seizures","volume":"101","author":"Rogawski","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01359-3_bib42","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/epi.16279","article-title":"Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participants","volume":"60","author":"French","year":"2019","journal-title":"Epilepsia"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01359-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:33:10Z","timestamp":1761805990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1878747923000144"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01359-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure Rescue Therapies: Comparing Approved and Commonly Used Benzodiazepine Formulations","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01359-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}